WHO discourages use of GSK, Regeneron antibody drugs against omicron

GSK's and Regeneron's COVID-19 treatments don't work against omicron and its subvariants, a World Health Organization panel said Sept. 16. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive